Regencell Bioscience Holdings Limited RGC · SEC Filings

10

Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Me...

Price5.625

Market Cap2.79 B

Float17.3 M

CountryHK

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

Financials

TYPE

HEADLINE

FILED AT

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Oct 7, 2026

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Oct 31, 2025

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Oct 25, 2024

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Oct 27, 2023

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Oct 31, 2022

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Oct 29, 2021

News

TYPE

HEADLINE

FILED AT

6-K

Regencell Bioscience Holdings Limited Announces Closing of $20 Million Registered Direct Offering

May 22, 2026

6-K

Regencell Bioscience Holdings Limited Announces $20 Million Registered Direct Offering

May 19, 2026

6-K

Regencell Bioscience Holdings Limited Announces Registered Direct Offering of Ordinary Shares

May 19, 2026

6-K

Regencell Bioscience Holdings Limited Reports Financial Results for First Half of Fiscal Year 2026

May 8, 2026

6-K

Regencell Bioscience Holdings Limited Announces Change of Independent Registered Public Accounting Firm

Apr 17, 2026

6-K

Regencell Bioscience Holdings Limited Files Form 6-K Regarding Sales Agreement

Mar 30, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

May 19, 2026

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

Mar 30, 2026

424B4

OFFERING | Shares amount: 2,300,000 | Share price: $9.50 | Offering amount: $21,850,000.00

Jul 20, 2021

Registrations

TYPE

HEADLINE

FILED AT

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

4

LO WILLIAM WING YAN DR (Reporting)

May 29, 2026

4

HUI EVANA YEE WAH (Reporting)

May 29, 2026

3

LO WILLIAM WING YAN DR (Reporting)

Mar 18, 2026

3

LO MARGARET HOOR HAN (Reporting)

Mar 18, 2026

3

HUI EVANA YEE WAH (Reporting)

Mar 18, 2026

3

CHAN HO YAU (Reporting)

Mar 18, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Jul 16, 2021

CORRESP

Form CORRESP - Correspondence

Jul 13, 2021

CORRESP

Form CORRESP - Correspondence

Jul 13, 2021

CORRESP

Form CORRESP - Correspondence

Jun 22, 2021

LETTER

Form UPLOAD - SEC-generated letter

Jun 21, 2021

CORRESP

Form CORRESP - Correspondence

Jun 11, 2021